Results 1 to 10 of about 1,970 (174)

Machine learning model for early diagnosis of breast cancer based on PiRNA expression with CA153 [PDF]

Scientific Reports
PIWI-interacting RNAs (piRNAs) have been implicated in the biological processes of various cancers. This study aimed to investigate the diagnostic potential of circulating piRNAs in breast cancer (BC) using machine learning (ML) frameworks.
Limin Niu, Jinming Zhao, Zhao Jinming
exaly   +6 more sources

Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge [PDF]

PLoS ONE, 2016
The aim of this study was to assess the diagnostic values of three breast tumor markers (i.e., CEA, CA153 and CA125) in milk and nipple discharge in the prediction of different breast diseases diagnoses.Three hundred thirty-six patients (96 breast cancer
Yu Mei, Jianli Wang
exaly   +6 more sources

CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis [PDF]

PLoS ONE, 2016
PURPOSE:Many studies have reported that carbohydrate antigen 153 (CA153) in breast secretions (BS) can discriminate breast cancer (BC) patients from healthy individuals, indicating CA153 in BS as a potential index for BC.
Yifan Sun
exaly   +6 more sources

Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients [PDF]

Journal of Medical Biochemistry
Background: It is an important clinical means to identify benign and malignant breast diseases caused by nipple discharge through the detection and analysis of components in nipple discharge.
Geng Jun, Jinli Shi, Guo Weina, Li Haiyan, Dan Yang, Gao Yan   +5 more
doaj   +4 more sources

Monitoring of postoperative neutrophil-to-lymphocyte ratio, D-dimer, and CA153 in: Diagnostic value for recurrent and metastatic breast cancer [PDF]

Frontiers in Surgery, 2023
ObjectiveThis stydy aims to assess the value of monitoring of postoperative neutrophil-to-lymphocyte ratio (NLR), D-dimer, and carbohydrate antigen 153 (CA153) for diagnosis of breast cancer (BC) recurrence and metastasis.Materials/MethodsA cohort of 252
Zhiyao Ren, Zhiyao Ren, Jing Yang, Jing Yang, Jiahui Liang, Jiahui Liang, Yunfeng Xu, Yunfeng Xu, Guanda Lu, Yanxun Han, Jie Zhu, Husheng Tan, Husheng Tan, Tao Xu, Min Ren, Min Ren   +15 more
doaj   +4 more sources

Integrative approach for enhanced ovarian cancer diagnosis: cytology and biomarkers [PDF]

Discover Oncology
Background This study evaluates the diagnostic value of routine cytology and liquid-based cytology (LBC) in detecting malignant cells in ovarian cancer-associated serous effusions and explores the clinical significance of CA125 and CA153 in single and ...
Shuangyan Chen, Lixiu Cai, Daoyin Zhou, Yan Chen   +3 more
doaj   +3 more sources

Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

BMC Cancer, 2022
Background Breast cancer (BCa) is the leading cause of cancer deaths among women. Reliable biomarkers for early diagnosis and metastasis prediction are essential to improve the prognosis of BCa.
Yunli Zhou, Li Ren, Dong Dong
exaly   +4 more sources

A Retrospective Analysis of a Serum Multi-Biomarker (CA153, TSGF, and CYFRA 21-1) Logistic Regression Model for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer [PDF]

Breast Cancer: Targets and Therapy
Limei He,1,* Weihong Zhang,2,* Libin Huang,1,* Xi Lin,1 Weiming Huang1 1Department of Medical Oncology, The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, 351100, People’s Republic
He L, Zhang W, Huang L, Lin X, Huang W
doaj   +3 more sources

Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer

World Journal of Surgical Oncology
Objective The aim of this study was to establish a preoperative model to predict the outcome of primary debulking surgery (PDS) for advanced ovarian cancer (AOC) patients by combing Suidan predictive model with HE4, CA125, CA153 and ROMA index.
Yue Jia, Yaping Jiang, Xiaoqi Fan, Ya Zhang, Kun Li, Haohan Wang, Xianling Ning, Xielan Yang   +7 more
exaly   +4 more sources

Clinical significance of serum miR-21, CA153 and CEA in breast cancer

International Journal of Fauna and Biological Studies, 2021
The Objective: one of the essential regulators of carcinogenesis is MicroRNA-21 (miR-21). Yet little light has been shed on its effectiveness as a tumor marker compared to the conventional ones. Comparing the diagnostic value of established tumor markers in breast cancer (BC) such as carcinoembryonic antigen (CEA) and CA153 with circulating level of ...
Hawar Hawar, Mhsin Mhamad, Barzan Ahmad, Halo Qadr   +3 more
exaly   +4 more sources